News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TRANSGENE (TRGNY) Says Experimental Cancer Drug Has ‘Enormous Potential’



3/16/2011 7:28:43 AM

Bloomberg -- Transgene SA (TNG), a French biotechnology company, is “very confident” about the prospects of an experimental cancer treatment now in clinical testing, Chief Executive Officer Philippe Archinard said.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES